Anhydrous Amiloride Hydrochloride

Phase 3Small molecule

AAssistance Publique - Hôpitaux de Paris

Anhydrous Amiloride Hydrochloride is one of 5 small molecule programs targeting Nephrogenic Diabetes Insipidus. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Nephrogenic Diabetes InsipidusActive, not recruiting

Nephrogenic Diabetes InsipidusPhase 3

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Nephrogenic Diabetes Insipidus

#DrugCompanyPhaseTrials

Anhydrous Amiloride Hydrochloride

AAssistance Publique - Hôpitaux de Paris

Phase 3

1 2

Viagra

VViatris Specialty LLC

Preclinical

1 3

Indocin

CCosette Pharmaceuticals, Inc.

Preclinical

1 4

Calcitonin

TTarsa Therapeutics, Inc.

Preclinical

1 5

Diuril

SSalix

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Nephrogenic Diabetes Insipidus1 trial

AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium

Active, not recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT05044611·148 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Anhydrous Amiloride Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anhydrous Amiloride Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anhydrous Amiloride Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAssistance Publique - Hôpitaux de Paris

Anhydrous Amiloride Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Nephrogenic Diabetes Insipidus1 trial

References

Drug Info

Quick Facts

Related News